Indo Ural Medicine And Education Private Limited
Founded in 2021 and headquartered in Gujarat, India.
2021 | Surat, Gujarat (India) | Active
Indo Ural Medicine And Education Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 10.00 K
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Indo Ural Medicine And Education
Indo Ural Medicine And Education Private Limited (IUMAEPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2021 (Three years and seven months 1 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Manidra Kaushik and Shailja Kaushik serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999GJ2021PTC124472
- Company No.
124472
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Business Services
Who are the key members and board of directors at Indo Ural Medicine And Education?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manidra Kaushik  | Director | 28-Jul-2021 | Current |
| Shailja Kaushik | Director | 28-Jul-2021 | Current |
Financial Performance of Indo Ural Medicine And Education.
Enhance accessibility to Indo Ural Medicine And Education's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Indo Ural Medicine And Education?
Unlock access to Indo Ural Medicine And Education's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indo Ural Medicine And Education?
Indo Ural Medicine And Education has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indo Ural Medicine And Education, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo Ural Medicine And Education's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.